16.77 USD
-0.8 (-4.53%)
16.77 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 89% to MPLT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 31.62. This target is 88.55% above the current price.
MPLT was analyzed by 9 analysts. The buy percentage consensus is at 89. So analysts seem to be very confident about MPLT.
MPLT was analyzed by 9 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-21 | Leerink Partners | Initiate | Outperform |
| 2025-11-21 | Stifel | Initiate | Buy |
| 2025-11-21 | Morgan Stanley | Initiate | Overweight |
| 2025-11-21 | Jefferies | Initiate | Buy |
MAPLIGHT THERAPEUTICS INC / MPLT FAQ
Can you provide the average price target for MAPLIGHT THERAPEUTICS INC stock?
9 analysts have analysed MPLT and the average price target is 31.62 USD. This implies a price increase of 88.55% is expected in the next year compared to the current price of 16.77.
How do analysts rate MAPLIGHT THERAPEUTICS INC (MPLT)?
The consensus rating for MAPLIGHT THERAPEUTICS INC (MPLT) is 88.8889 / 100 . This indicates that analysts generally have a positive outlook on the stock.